Several new multitarget stool-based screening tests on the horizon may improve early colorectal cancer detection, according to findings from recent analyses.
These new tests aren't radical departures from the standard FIT. Like the standard test, the multitarget FIT uses antibodies to test for hemoglobin in stool samples. But these multitarget approaches take the standard FIT a step further by testing for additional DNA, RNA, or protein biomarkers associated with CRC to help improve early detection.— as well as a third noninvasive CRC screening test, guaiac fecal occult blood test .
Three new noninvasive multitarget tests under investigation — an updated DNA-based test, Cologuard 2.0 ; an RNA-based test, ColoSense ; and a protein-based test from CRCbioscreen — may be able to do just that. An updated version of the stool FIT-DNA is currently under development. Dubbed Next Generation Cologuard, or Cologuard 2.0, this multitarget test detects three novel methylated DNA markers along with fecal hemoglobin.comparing Cologuard 2.
Compared with the original Cologuard, Cologuard 2.0's sensitivity improved slightly for CRC, from 92% to 93.9%,; for advanced precancerous lesions, from 42% to 43.4%; and for high-grade dysplasia, from 69% to 75%. Specificity also improved with the latest version, ColoSense showed higher sensitivity than standard FIT for the presence of CRC and advanced adenomas . In the group aged 45-50 years, the RNA-based test had a sensitivity of 100% for CRC, correctly identifying all five people with colonoscopy-confirmed CRC, and 45% for advanced adenomas.
Overall, the analysis included stool samples from 13,187 patients aged 55-75 years who were in the Netherlands' national CRC screening program. Stool samples were evaluated with both the multitarget test and the standard FIT, using a positivity cutoff ≥ 47 µg hemoglobin/g feces. Colonoscopy data were available for only 1270 participants.
Perhaps the most telling comparison occurred in scenario 2, with both tests set at the same low positivity threshold to minimize false-positives.
Colorectal Cancer (CRC) Healthcare And Medical Technology Health And Medical Tech Health And Med Tech Health And Medical Technology Healthcare Technology Medical Technology Bowel Preparation Colonoscopy Cancer Malignant Neoplasia Carcinoma Malignant Neoplasm Colon Cancer Malignant Neoplasm Of The Colon Malignant Neoplasm Of The Large Intestine Preventive Screening
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
What to know about the Moscow concert attack and what's next in the caseRussia is still reeling from Friday's attack. Authorities have confirmed at least 137 dead. Suspects, some showing signs of torture, have been charged. Here are other key developments.
Baca lebih lajut »
Everything We Know About The Next Avatar After KorraCan they reveal the next Avatar already??
Baca lebih lajut »
Which neighborhood should be featured next on KSAT’s Know My Neighborhood?The team behind the project described it as “a deep dive into issues on a neighborhood-by-neighborhood basis.”
Baca lebih lajut »
We Finally Know Whether Jenn Will Be the Next BacheloretteIs Jenn the next Bachelorette for 2024? The answer seems to be no.
Baca lebih lajut »
Everything we know about Lunar Lake, Intel’s big next-generation chipsIntel's Lunar Lake is a mobile-first generation of energy efficient CPUs that may well launch before the end of 2024. Here's what we know so far.
Baca lebih lajut »
What investors need to know about ‘Dencun,’ Ethereum’s next big tech upgradeEthereum's next big tech upgrade, dubbed 'Dencun,' is scheduled to take place Wednesday.
Baca lebih lajut »